News

CedarDB pushed to the limit in improbable gaming experiment The world has moved on from making Doom run on increasingly ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Treatment with the gene therapy exagamglogene autotemcel (exa-cel) led to significant and sustained improvements in health-related quality of life for individuals with severe sickle cell disease (SCD) ...
Hypertrophic cardiomyopathy (HCM) is the most common hereditary cardiac condition and the leading cause of sudden cardiac death (SCD) in young adults. Given that SCD can be the first and most ...
The breakthrough was achieved in an Investigator-Initiated Trial (IIT) conducted in collaboration with the First Affiliated Hospital of Guangxi Medical University. The patient demonstrated a ...
Scandium Canada Ltd. operates as a mineral exploration company in Canada. The company primarily explores for gold, scandium, and base metal deposits. It also holds 100% interests in the Crater Lake ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the SCD ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...